Pharma Press Releases By Categories

GlaxoSmithKline plc and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI), under the brand name Trelegy Ellipta, for the long-term, once-daily, maintenance treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis…
Axion BioSystems, the global leader in microelectrode array (MEA) technology, introduces the next generation of MEA platforms, Maestro Pro and Maestro Edge.Excitable cells play a fundamental role in life, from heart beats to brain function. Maestro MEA systems capture live-cell activity from electroactive cells in real-time, allowing scientists to recreate…
Belgium-based CDMO Kaneka Eurogentec, a unit of Japanese chemical giant Kaneka, will build a new biologics manufacturing facility as part of the company’s expansion into large-scale production of biopharmaceuticals. Construction is expected to begin in the coming months at a site located near Eurogentec’s current production facility in Seraing, Belgium.…
Aurigene Discovery Technologies Ltd, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd and Curis, Inc. have announced plans to initiate a Phase 2 trial of CA-170, a PDL1-VISTA inhibitor to be conducted at sites in India. This was announced following the presentation of preliminary data from the initial 34…
Novartis announced, first of its kind phase III data showing Cosentyx (secukinumab) delivered high and long-lasting skin clearance in patients with moderate-to-severe plaque psoriasis at 5 years. These data were presented for the first time at the 26th European Academy of Dermatology and Venereology (EADV) Congress in Geneva, Switzerland.  …
Page 1 of 72

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: